Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study

Br J Haematol. 2017 Sep;178(5):816-819. doi: 10.1111/bjh.14170. Epub 2016 Jun 13.

¹ Medical College of Wisconsin, Milwaukee, WI, USA.
² Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
³ City of Hope Cancer Center, Los Angeles, CA, USA.
⁴ Dana-Farber Cancer Institute, Boston, MA, USA.
⁵ National Marrow Donor Program, Minneapolis, MN, USA.
⁶ Vanderbilt University Medical Center and Veterans Affairs Tennessee Valley Healthcare System, Nashville, TN, USA.
⁷ MD Anderson Cancer Research Center, Houston, TX, USA.
⁸ The EMMES Corporation, Rockville, MD, USA.
⁹ Southern California Kaiser Permanente Medical Group, Los Angeles, USA.
¹⁰ University of Minnesota, Minneapolis, MN, USA.
¹¹ Hackensack University Medical Center, Hackensack, NJ, USA.
¹² University of Pennsylvania Abramson Cancer Center, Philadelphia, PA, USA.
¹³ Fred Hutchison Cancer Center, Seattle, WA, USA.

No abstract available

Keywords: freelite; hevylite; myeloma.

Publication types